Wound control in patients on anticoagulants is challenging and often leads to poor hemostasis. They have a higher tendency to develop alveolar osteitis after tooth extraction. The application of a hemostatic dressing that has a high absorbing capacity and is loaded with an antifibrinolytic drug could help in controlling the bleeding. Alginate/nano-hydroxyapatite (SA/Nano-HA) composite aerogels loaded with tranexamic acid (TXA) were prepared. Nano-HA served as a reinforcing material for the alginate matrix and a source of calcium ions that helps in blood clotting. It influenced the porosity and the water uptake capacity. TXA release from SA/Nano-HA aerogels showed a biphasic profile for up to 4 h. Blood coagulation studies were performed on human whole blood. The TXA-loaded aerogel significantly reduced the clotting time by 69% compared to the control (p < 0.0001). Recalcification time was significantly reduced by 80% (p < 0.0001). Scanning electron microscopy analysis revealed the porous nature of the aerogels and the ability of the optimum aerogel to activate and adhere platelets to its porous surface. The cell migration assay showed that there was a delay in wound healing caused by the TXA aerogel compared to the control sample after treating human fibroblasts. Results suggest that the developed aerogel is a promising dressing that will help in hemostasis after tooth extraction.
10 May 2024 in International Journal of Pharmaceutics
Thiamine hydrochloride has been suggested as a natural, safe yet effective alternative for chemical insect repellents. However, there is a demand for a reassessment of the minimum required dose that is sufficient to perform a topical repellency on the human skin. Therefore, the purpose of the current work is to establish a dose–response curve from which the effective dose (ED) is calculated. A series of increasing concentrations of thiamine hydrochloride were applied to the forearm of adult volunteers, the number of bites was counted and the percent repellency calculated accordingly. Data of percent repellency were converted to probit values which were plotted against log doses. A linear relation was obtained from the dose–response curve with an r2 = 0.958. Statistical validation of the equation was tested through linear regression analysis, where the slope and intercept were found significant from zero. No significant difference was shown between observed and expected responses (p > 0.05). ED 50 and 99.9% were computed from the linear equation and found to be 4.57 and 344 mg, respectively. This finding can be supported by future works in which a proper formulation of thiamine hydrochloride in the respective doses would be presented. One can get prolonged safe protection against insect bites.
1 November 2021 in Journal of Pharmaceutical Sciences
Background: Bone tissue regeneration based on the use of porous biomaterial scaffolds is considered a promising approach for treating bone defects and fractures healing. A porous alginate scaffold comprising hydroxyapatite nanoparticles loaded with tranexamic acid was formulated. The prepared scaffolds were characterized in terms of the release profile of tranexamic acid and scanning electron microscopy imaging. A cranial bone defect in rabbits (6 defects/3 rabbits/group) was used as a model for the assessment of hemostatic activity of the used scaffolds and the assessment of the bone formation histomorphometrically after its application for 14 days. Results: The scaffold appeared with irregular porous structure and controlled the release of tranexamic acid over 4 h. The hemostatic time of the medicated and non-medicated scaffolds were 20 and 60 s, respectively. They were significantly lower than the control group (200 s, p < 0.05). The microscopic examination was done after staining histologically prepared sections from the bone defect with Masson trichrome stain and the area % of the newly developed bone was computed. For the medicated group, the new bone area % (75.8 ± 4.9%) was significantly higher than the non-medicated group (58.1 ± 5.9%, p < 0.001). Both groups were significantly larger than the control group that showed bone area % of 43.1 ± 5.6 (p < 0.05). The histomorphometric analysis showed that the medicated scaffold-treated group had more mineralized newly formed bone tissue and smaller amount of soft tissue and residual materials. In contrast, the non-medicated scaffold showed non-mineralized bone cells with larger soft tissue and residual materials. Conclusion: These results suggested the promising effect of the tranexamic acid-loaded scaffolds in minimizing the time to reach hemostasis by stabilization of the formed hematoma. Additionally, they could improve the quality (mineralization) and the quantity (amount) of the newly formed bone. Graphical
13 November 2025 in Journal of Drug Delivery Science and Technology